VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an ...
VBI's shares plunge after hep B vaccine fails secondary goal in late-stage trial - Reuters
Read More
No comments:
Post a Comment